• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测严重烧伤患者临床进展的诱饵受体 3 水平。

Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn Patients.

机构信息

Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China.

First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

出版信息

J Burn Care Res. 2021 Sep 30;42(5):925-933. doi: 10.1093/jbcr/irz170.

DOI:10.1093/jbcr/irz170
PMID:34213565
Abstract

The clinical value of Decoy receptor 3 (DcR3) in severe burn is investigated. Ten patients with severe burns were monitored for DcR3, PCT, CRP, IL6, SOFA score, white blood cell (WBC), and platelet. The correlations were analyzed. DcR3 increased on day 1. The nonsurvivors had a steady high level of DcR3 while the survivors had a relatively low level of DcR3. The peak magnitude of DcR3 was high in five nonsurvivors and low in five survivors without overlap. Three patients had a continuously increasing DcR3 level and then died. In the other two nonsurvivors, DcR3 reached the peak and then decreased before death. DcR3 correlated well with PCT (ρ = 0.4469, P < .0001), less with CRP, platelet, IL6, SOFA score and WBC (ρ = 0.4369, 0.4078, 0.3995, 0.2631, 0.1504, respectively, all P < .001). To explore the mechanisms, the HaCaT or THP-1 cells were stimulated by the plasma of burn patients, 45°C, LPS or stimulators of TLRs or NOD2 (PGN, CL264, MDP, iE-DAP, Gardiquimod), and their DcR3 was increased, which could be reduced by GDC-0941 or BEZ235 (inhibitors of PI3K and mTOR). The levels of DcR3 appeared to be a useful biomarker for monitoring the clinical severity and a predictor of mortality of severe burns.

摘要

研究了诱饵受体 3 (DcR3) 在严重烧伤中的临床价值。监测了 10 名严重烧伤患者的 DcR3、PCT、CRP、IL6、SOFA 评分、白细胞 (WBC) 和血小板。分析了相关性。DcR3 在第 1 天增加。非幸存者的 DcR3 水平持续升高,而幸存者的 DcR3 水平相对较低。5 名非幸存者的 DcR3 峰值幅度较高,5 名幸存者的 DcR3 峰值幅度较低,没有重叠。3 名患者的 DcR3 水平持续升高后死亡。在另外 2 名非幸存者中,DcR3 达到峰值后在死亡前下降。DcR3 与 PCT 相关性良好 (ρ = 0.4469,P <.0001),与 CRP、血小板、IL6、SOFA 评分和 WBC 的相关性稍差 (ρ = 0.4369,0.4078,0.3995,0.2631,0.1504,均 P <.001)。为了探讨机制,用烧伤患者的血浆、45°C、LPS 或 TLRs 或 NOD2 的激动剂 (PGN、CL264、MDP、iE-DAP、Gardiquimod) 刺激 HaCaT 或 THP-1 细胞,其 DcR3 增加,用 GDC-0941 或 BEZ235 (PI3K 和 mTOR 的抑制剂) 可降低其 DcR3。DcR3 水平似乎是监测严重烧伤临床严重程度和预测死亡率的有用生物标志物。

相似文献

1
Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn Patients.监测严重烧伤患者临床进展的诱饵受体 3 水平。
J Burn Care Res. 2021 Sep 30;42(5):925-933. doi: 10.1093/jbcr/irz170.
2
Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.血清诱饵受体3是非特应性哮喘患者疾病严重程度的生物标志物。
J Formos Med Assoc. 2017 Jan;116(1):49-56. doi: 10.1016/j.jfma.2016.01.007. Epub 2016 Feb 22.
3
Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.诱饵受体 3 联合降钙素原和可溶性尿激酶型纤溶酶原激活物受体对脓毒症的诊断价值。
Cell Mol Biol Lett. 2018 May 9;23:22. doi: 10.1186/s11658-018-0087-z. eCollection 2018.
4
Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.血清诱骗受体3水平与髓过氧化物酶-抗中性粒细胞胞浆抗体相关性肾血管炎的疾病活动度相关。
Clin Rheumatol. 2016 Oct;35(10):2469-76. doi: 10.1007/s10067-016-3321-y. Epub 2016 Jun 1.
5
Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.外周血中诱饵受体3水平可预测急性呼吸窘迫综合征的预后。
Am J Respir Crit Care Med. 2009 Oct 15;180(8):751-60. doi: 10.1164/rccm.200902-0222OC. Epub 2009 Jul 30.
6
The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.原发性干燥综合征患者中死亡诱饵受体3的表达增加。
Clin Rheumatol. 2015 May;34(5):879-85. doi: 10.1007/s10067-014-2853-2. Epub 2015 Jan 8.
7
Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children.血清诱饵受体 3(DcR3):儿童特应性哮喘有前途的生物标志物。
Immunol Res. 2021 Dec;69(6):568-575. doi: 10.1007/s12026-021-09218-z. Epub 2021 Aug 12.
8
Increased circulating levels of tumor necrosis factor-like cytokine 1A and decoy receptor 3 correlate with SYNTAX score in patients undergoing coronary surgery.接受冠状动脉手术的患者中,肿瘤坏死因子样细胞因子1A和诱饵受体3的循环水平升高与SYNTAX评分相关。
J Int Med Res. 2018 Dec;46(12):5167-5175. doi: 10.1177/0300060518793787. Epub 2018 Sep 13.
9
Usefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients With Multivessel Coronary Artery Disease.循环诱饵受体3在预测多支冠状动脉疾病患者冠状动脉疾病严重程度及未来主要不良心血管事件中的应用价值
Am J Cardiol. 2015 Oct 1;116(7):1028-33. doi: 10.1016/j.amjcard.2015.06.041. Epub 2015 Jul 16.
10
Elevated serum levels of decoy receptor 3 are associated with disease severity in patients with hemorrhagic fever with renal syndrome.肾综合征出血热患者血清中诱骗受体3水平升高与疾病严重程度相关。
Intern Emerg Med. 2015 Aug;10(5):567-73. doi: 10.1007/s11739-015-1195-7. Epub 2015 Feb 3.

引用本文的文献

1
Decoy receptor 3 as a prognostic biomarker for sepsis and septic shock according to the Sepsis-3 definitions.根据脓毒症-3定义,诱饵受体3作为脓毒症和脓毒性休克的预后生物标志物。
Front Cell Infect Microbiol. 2025 Mar 7;15:1529917. doi: 10.3389/fcimb.2025.1529917. eCollection 2025.
2
Inhibitory mechanisms of decoy receptor 3 in cecal ligation and puncture-induced sepsis.诱饵受体 3 在盲肠结扎和穿刺诱导脓毒症中的抑制机制。
mBio. 2024 Jun 12;15(6):e0052124. doi: 10.1128/mbio.00521-24. Epub 2024 May 3.
3
Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis.
DcR3 在脓毒症诊治中研究进展。
Int J Mol Sci. 2023 Aug 18;24(16):12916. doi: 10.3390/ijms241612916.